RASP
Price:
$0.004
Market Cap:
$3.09M
Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
Industry
Biotechnology
IPO Date
2015-02-24
Stock Exchange
OTC
Ticker
RASP
According to Actavia Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.40. This represents a change of -98.68% compared to the average of -30.26 of the last 4 quarters.
The mean historical PE Ratio of Actavia Life Sciences, Inc. over the last ten years is -69.78. The current -0.40 PE Ratio has changed -42.67% with respect to the historical average. Over the past ten years (40 quarters), RASP's PE Ratio was at its highest in in the March 2022 quarter at 1.46. The PE Ratio was at its lowest in in the September 2015 quarter at -1271.15.
Average
-69.78
Median
-9.56
Minimum
-394.46
Maximum
-0.97
Discovering the peaks and valleys of Actavia Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 388.31%
Maximum Annual PE Ratio = -0.97
Minimum Annual Increase = -91.24%
Minimum Annual PE Ratio = -394.46
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.60 | 113.40% |
| 2022 | -1.22 | -74.17% |
| 2021 | -4.72 | 388.31% |
| 2020 | -0.97 | -91.24% |
| 2019 | -11.04 | 36.63% |
| 2018 | -8.08 | -72.98% |
| 2017 | -29.90 | -62.47% |
| 2016 | -79.67 | -79.80% |
| 2015 | -394.46 | 138.92% |
| 2014 | -165.11 | -70.68% |
The current PE Ratio of Actavia Life Sciences, Inc. (RASP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.85
5-year avg
-4.11
10-year avg
-69.78
Actavia Life Sciences, Inc.’s PE Ratio is greater than ChitogenX Inc. (-0.44), greater than Wesana Health Holdings Inc. (-1.76), less than Innovation Pharmaceuticals Inc. (-0.11), less than Tevano Systems Holdings Inc. (-0.17), less than Lift & Co. Corp. (-0.01), greater than Nascent Biotech, Inc. (-1.18), less than Viracta Therapeutics, Inc. (-0.02), less than RespireRx Pharmaceuticals Inc. (-0.10), greater than MedGen, Inc. (-600.00), less than Paradigm Medical Industries, Inc. (-0.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.44 | $301.50K | |
| -1.76 | $244.77K | |
| -0.11 | $362.84K | |
| -0.17 | $744.00 | |
| -0.01 | $281.98K | |
| -1.18 | $740.53K | |
| -0.02 | $388.70K | |
| -0.10 | $657.75K | |
| -600.00 | $90.31K | |
| -0.01 | $324.88K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actavia Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Actavia Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Actavia Life Sciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Actavia Life Sciences, Inc. (RASP)?
What is the highest PE Ratio for Actavia Life Sciences, Inc. (RASP)?
What is the 3-year average PE Ratio for Actavia Life Sciences, Inc. (RASP)?
What is the 5-year average PE Ratio for Actavia Life Sciences, Inc. (RASP)?
How does the current PE Ratio for Actavia Life Sciences, Inc. (RASP) compare to its historical average?